PT1089720E - Sistema terapeutico transdermico que contem hormonas e inibidores de cristalizacao - Google Patents

Sistema terapeutico transdermico que contem hormonas e inibidores de cristalizacao

Info

Publication number
PT1089720E
PT1089720E PT99927905T PT99927905T PT1089720E PT 1089720 E PT1089720 E PT 1089720E PT 99927905 T PT99927905 T PT 99927905T PT 99927905 T PT99927905 T PT 99927905T PT 1089720 E PT1089720 E PT 1089720E
Authority
PT
Portugal
Prior art keywords
therapeutic system
crystallization inhibitors
system containing
containing hormones
crystallization
Prior art date
Application number
PT99927905T
Other languages
English (en)
Inventor
Lucio Rovati
Antonino Santoro
Original Assignee
Rotapharm B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotapharm B V filed Critical Rotapharm B V
Publication of PT1089720E publication Critical patent/PT1089720E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT99927905T 1998-06-25 1999-06-08 Sistema terapeutico transdermico que contem hormonas e inibidores de cristalizacao PT1089720E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19828274A DE19828274C2 (de) 1998-06-25 1998-06-25 Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren

Publications (1)

Publication Number Publication Date
PT1089720E true PT1089720E (pt) 2002-10-31

Family

ID=7871951

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99927905T PT1089720E (pt) 1998-06-25 1999-06-08 Sistema terapeutico transdermico que contem hormonas e inibidores de cristalizacao

Country Status (7)

Country Link
EP (1) EP1089720B1 (pt)
AT (1) ATE216876T1 (pt)
AU (1) AU4508799A (pt)
DE (2) DE19828274C2 (pt)
ES (1) ES2178445T3 (pt)
PT (1) PT1089720E (pt)
WO (1) WO1999066907A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10025971B4 (de) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
TWI277418B (en) 2001-06-18 2007-04-01 Noven Pharma Enhanced drug delivery in transdermal systems
JP6654365B2 (ja) * 2015-06-17 2020-02-26 日東電工株式会社 貼付製剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
DE19728517C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico

Also Published As

Publication number Publication date
WO1999066907A1 (de) 1999-12-29
AU4508799A (en) 2000-01-10
DE19828274C2 (de) 2002-11-28
DE19828274A1 (de) 1999-12-30
DE59901355D1 (de) 2002-06-06
ES2178445T3 (es) 2002-12-16
EP1089720A1 (de) 2001-04-11
EP1089720B1 (de) 2002-05-02
ATE216876T1 (de) 2002-05-15

Similar Documents

Publication Publication Date Title
WO1999066901A3 (de) Transdermales therapeutisches system, enthaltend hormone und kristallisationsinhibitoren
CO4810224A1 (es) Dispositivo para el suministro transdermico de flurbiprofen
HUP0103715A2 (hu) Topikus tapasz savcsoportot tartalmazó nemszteroid reumaellenes hatóanyaggal
HUP0101351A2 (hu) Diklofenak transzdermális bevitelére szolgáló eszköz
DK0659081T3 (da) Dexpanthenol-holdigt plaster til transdermal applikation af steroidhormoner
ES2152979T3 (es) Sistema terapeutico transdermal que contiene estradiol.
BR9609794A (pt) Sistema terapêutico transdermal (stt)
WO1999012529A3 (de) Transdermales therapeutisches system mit haftklebender reservoirschicht und unidirektional elastischer rückschicht
DK1089722T3 (da) Transdermalt plaster af matrixtypen til steroidhormoner
NO960487D0 (no) Transdermalt medikament leveringssystem med lav fluksinnretning
KR950031058A (ko) 경피 흡수 제제
NO994042D0 (no) Transdermal anordning til levering av testosteron
PT101019A (pt) Sistema terapeutico transdermico contendo inibidores de cristalizacao, nomeadamente, dioxido de silicio e colesterol
NO20015614D0 (no) Transdermalt terapeutisk system (TTS) som inneholder tolterodin
ATE181827T1 (de) Estradiolhaltiges pflaster
KR910011265A (ko) 에스트로겐-함유 겔 제제
NZ502351A (en) Transdermal therapeutical system for delivery of levonorgestrel
CA2039869A1 (en) Percutaneous-administration-type pharmaceutical preparation of nitroglycerin
PT1089720E (pt) Sistema terapeutico transdermico que contem hormonas e inibidores de cristalizacao
ES2165232T3 (es) Sistema terapeutico transdermico (tts) que contiene oxibutinina.
BR0008640A (pt) Dispositivo de administração transdérmica
JPS53121833A (en) Method of protecting surface
MY119647A (en) Prosess for stabilizing (meth) acrylic acid esters against unwanted radical polimerization
ES2155902T3 (es) Composicion reticulable para sustratos de revestimiento y procedimiento de revestimiento que utiliza esta composicion.
PL309602A1 (en) Nitroglycerin container plaster, method of obtaining same and application thereof